1 / 34

Drug Free Moms and Babies Project

Explore the comprehensive services, demographics, and outcomes of pregnant and postpartum women with substance use disorders participating in the Drug Free Moms and Babies program. Learn effective strategies and discuss obstacles in caring for this vulnerable population.

paulinek
Download Presentation

Drug Free Moms and Babies Project

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Drug Free Moms and Babies Project An analysis of a three-year pilot project

  2. Learning Objectives • Identify comprehensive services provided to pregnant and postpartum women with substance use disorders participating in the Drug Free Moms and Babies program in four pilot project sites. • Describe the demographics of Drug Free Moms and Babies program participants. • Identify effective strategies to meet the complex needs of pregnant and postpartum women with substance use disorders. • Learn about obstacles to caring for this vulnerable and special needs population. • Discuss outcome data of program participants.

  3. DFMB Project Goal To develop, evaluate, document, and replicate programs that support healthy baby outcomes by providing prevention, early intervention, treatment, and recovery services for pregnant and postpartum women with substance use disorders.

  4. Evaluation Design Qualitative Evaluation Quantitative Evaluation RedCap Database Demographic Information Medical and Substance Abuse Histories Quantity and Depth of Services Outcome Data Drug Screens Cord Tissue • Program Design • Organizational Characteristics • SBIRT Process • Staffing • Services • Partners • Yearly Interviews • Quarterly Check-Ins

  5. DFMB Project History • Began project development in 2011 • Started awarding funds in 2012 • Four pilot sites selected: • Shenandoah Valley Medical Center Shenandoah Community Health • Thomas Memorial Hospital • Greenbrier Valley Medical Center Greenbrier Physicians Clinic • WVU Medicine Obstetrics and Gynecology Department

  6. Brief Design Overview SBIRT Model • Screening • Brief Intervention • Referral • Treatment Treatment Provided • Case Management • Counseling: Individual, Group, Family • Peer Recovery Coaching • Medication Assisted Treatment • Educational Workshops/Coaching • Drug Screens • Incentive Programs

  7. Shenandoah Community Health • Located in Martinsburg, West Virginia • Serves Berkeley, Jefferson, and Morgan Counties in WV and surrounding areas in MD and VA • DFMB services began in May 2012 • DFMB Staff: • Clinical Director (10%) • Licensed Professional Counselor (50%) • Recovery Coach (75%) • Grant Administrator (10%)

  8. Shenandoah Community Health Treatment Unique Components One-stop-shop for medical and behavioral health services Onsite Peer Recovery Coach MAT with extensive monitoring and case management Collaborative treatment team • Psychiatric Services and Medication Assisted Treatment • Group Counseling • Individual Counseling • Peer Recovery Coaching • Incentives Program

  9. Thomas Memorial Hospital • Located in South Charleston, West Virginia • Serves 12 counties in southcentral and southwestern West Virginia • DFMB services began in August 2012 (Pregnancy Connections) • DFMB Staff: • Patient Coordinator (100%)

  10. Thomas Memorial Hospital Treatment Unique Components Extensive monitoring and case management MAT provided by Ob/Gyn Structured outpatient treatment program Mental health screenings and services Strong collaboration with hospital’s Mother-Baby unit • Individual Counseling • Group Counseling • Individualized Recovery Plans • Recovery Support • Community Resources • Community and Hospital Education • Incentives Program

  11. Greenbrier Physicians Clinic • Located in Ronceverte, West Virginia • Serves Greenbrier, Monroe, Pocahontas, Summers, Fayette, and Raleigh Counties in WV and Alleghany County, VA • DFMB services began in December 2012 • DFMB Staff: • Care Manager (100%)

  12. Greenbrier Physicians Clinic Treatment Unique Components Universal urine drug screens on all new OB patients Care Manager meets with all OB patients regardless of substance use Extensive brief intervention sessions Extensive case management • Case Management • Individual Counseling • Group Counseling • Extensive Brief Interventions and Education Sessions • Community Resources • Individualized Treatment Plans • Incentives Program

  13. WVU Medicine Obstetrics and Gynecology Department • Located in Morgantown, West Virginia • Serves statewide, as well as southwestern PA, western MD, and eastern OH • DFMB services began in August 2015 (ACE Project: Assist, Connect, Encourage) • DFMB Staff: • Principal Investigator • Licensed Clinical Social Worker • Patient Liaison (50%) • Peer Recovery Coach (50%)

  14. WVU Medicine Obstetrics and Gynecology Department Treatment Unique Components Patient Liaison meets with participants at prenatal meetings or in the community ACE support group meetings address the unique needs of pregnant women with substance use disorders Extensive facilitation of treatment and access to education • Case Management • Individual Counseling • Group Counseling • Community Resources and Referral • Parenting and Health Education • Incentives Program • Peer Recovery Coaching

  15. Lessons Learned • Takes more time than anticipated • A dedicated staff position is critical to moving the project forward • A collaborative treatment team needs to be developed and nurtured • Flexibility to enhance/revise program is needed

  16. Participants • Data Received by June 30, 2017 • Data Collected between 2012 - 2017 • 546 Entries from 4 Sites • 36 Readmissions • 510 Unduplicated

  17. Participants 1 Regional representation consistent with site locations (N=487) • 1% • 30% • 1% • 12% • 24% • 33% 2 4 3 5 6

  18. ProjectWATCH/Birth Score Substance-exposed pregnancies October 2016-April 2017 Includes DFMB participants State of perinatal health in WV 2016 data (WV health statistics center/vital statistics) Comparison data highlighted through out Comparison Data

  19. Demographics • Valid percentages or means presented • Number of unduplicated participants: 510 • Race/Ethnicity consistent with Appalachian demographics: • Race: 93.73% White • Ethnicity: 99.6% Non-Hispanic

  20. Demographics • Maternal Age: 26.23 (Range 16-43) • Number in Household: 3.13 (Range 1-8) • Number of Living Children: 1.97 (Range 0-8) • Marital Status: • Never married: 68% • Married: 18% • Other: 14% • Cohabitation (for those not married): Yes: 61% • PlannedPregnancy: 14% • Comparison • WV 2016: • Married: 54.4%

  21. Demographics Income • <$15,000: 70% • $15,000-$24,999: 17% • $25,000-$34,999: 9% • >$35,000: 4% • College or greater: 1% Education • Some elementary: 1% • Some high school: 34% • High school diploma or GED: 49% • Technical training: 6% • Some college: 10% • College or greater: 1%

  22. Demographics Insurance • Private: 5.6% • Medicaid: 92.8% • Other 1.6% Intention to Breastfeed • 63% Comparisons WATCH (all substance-exposed pregnancies): • Medicaid: 80.9% • Intention to Breastfeed: 31% All WV Births 2016: • Breastfeeding at time of discharge: 65.2% All WV births 2015: • Medicaid: 48%

  23. Substance Use Prior to Pregnancy During Pregnancy Alcohol: 12% Tobacco: 80% Cannabis: 53% Stimulant: 16% Hallucinogens: <1% Opioids (non-prescribed): 67% Other Substances: 26% • Comparisons • Tobacco: • WATCH: 68.5% • WV 2016: 25.2% • Drug use (illicit/ non-prescribed): • WV 2016: 7.7% • Alcohol: 61% • Tobacco: 91% • Cannabis: 83% • Stimulant: 41% • Hallucinogens: 10% • Opioids (non-prescribed): 77% • Other Substances: 40%

  24. Care and Treatment Trimester Entering Care • First: 63% • Second: 29% • Third: 8% Trimester Entering DFMB • First: 50% • Second: 35% • Third:16% Enrolled in Treatment (N=457) • Drugs (95%) • Alcohol (2%) • Both (3%) Treatment Types (can be more than one) • Medication Assisted Treatment: 275 (54%) • Counseling: 279 (55%) • Intensive Outpatient: 62 (12%) • Brief Intervention: 348 (68%) Comparison First trimester entering care: WV 2016: 79.5%

  25. Referrals Referred to other substance abuse treatment program? • Yes: 141 • Inpatient: 48 • Outpatient: 43 • Both: 50

  26. Outcomes 354 Program Completers

  27. Outcomes Positive Urine Drug Screens • For program completers (N=354) • Does not include positive drug screens prior to program entry • Positives generally defined as non-prescribed

  28. Outcomes Positive Urine Drug Screens • Earlier trimester entering program associated with improved outcomes • Improvements across all

  29. Outcomes • Comparison • Preterm: • WATCH: 14% • WV 2016: 11.8% For program completers (N=354), positive cord numbers may be conservative due to data entry of the pilot Birth Outcomes • Live, term birth: 83% • Live, preterm births: 8% Positive Cord Tissue • 131 (47%) • Of positives, for prescription drugs only? 33 (45%) NAS: • Yes: 112 (44%) • Comparison • NAS: • WATCH: 38% • WV 2016: 4.6%

  30. Summary: Demographics • DFMB Program is reaching high-risk, medically-underserved women, including high percentages of: • Low education • Low income • Medicaid insurance • Unplanned pregnancies

  31. Summary: Demographics • Comparisons with WATCH/Birth Score • Intent to breastfeed actually an outcome: higher percentages than Birth Score data • Otherwise, demographics consistently more high-risk • DFMB has the potential to expand: • Better regional medical coverage • Efforts targeting smoking and cannabis use during pregnancy • Expansion to include all substance-use pregnancies • Expand demographic reach (e.g. WATCH)

  32. Summary: Outcomes • Positive urine drug screens decreased from 80% at first trimester to 21% at delivery • Comparisons with WATCH/Birth Score • Lower pre-term delivery percentage • Higher percentage NAS diagnosis • Perhaps due to definition and increased awareness of newborn need for treatment • High percent on Medication Assisted Treatment

  33. Summary: Outcomes • DFMB has the potential to expand: • Getting women into DFMB and prenatal care sooner • Outcomes are among program completers, need to improve follow-up (especially post-delivery) • Number of readmissions suggests increased opportunity for expanding birth control education and options • Expansion of referral education and follow-up

  34. Questions and Answers

More Related